Invention Grant
- Patent Title: Compositions and methods for treatment of eye disorders
- Patent Title (中): 用于治疗眼部疾病的组合物和方法
-
Application No.: US13398542Application Date: 2012-02-16
-
Publication No.: US08592450B2Publication Date: 2013-11-26
- Inventor: Thomas Gadek , John Burnier
- Applicant: Thomas Gadek , John Burnier
- Applicant Address: US CA Brisbane
- Assignee: SARcode Bioscience Inc.
- Current Assignee: SARcode Bioscience Inc.
- Current Assignee Address: US CA Brisbane
- Agency: Troutman Sanders LLP
- Main IPC: A61K31/47
- IPC: A61K31/47
Abstract:
The present invention provides compounds and methods for the treatment of LFA-1 mediated diseases. In particular, LFA-1 antagonists are described herein and these antagonists are used in the treatment of LFA-1 mediated diseases. One aspect of the invention provides for diagnosis of an LFA-1 mediated disease and administration of a LFA-1 antagonist, after the patient is diagnosed with a LFA-1 mediated disease. In some embodiments, the LFA-1 mediated diseases treated are dry eye disorders. Also provided herein are methods for identifying compounds which are LFA-1 antagonists.
Public/Granted literature
- US20120232019A1 Compositions and Methods for Treatment of Eye Disorders Public/Granted day:2012-09-13
Information query
